T cell receptor beta chain variable region (TCRβ V region)

The T cell receptor beta chain variable region forms part of the antigen-binding site on αβ-type T-cell receptors. The β-chain pairs with an α-chain; both chains have highly diverse N-terminal domains generated through somatic recombination (V(D)J recombination). This process creates enormous variability—estimated at over 10^18 possible combinations—enabling recognition of virtually any peptide-MHC complex presented by other cells. The β-chain’s complementarity-determining regions (CDRs), especially CDR3 formed at the junctions between gene segments during recombination, are critical for determining antigen specificity. This molecular diversity underpins adaptive immunity’s ability to respond specifically to pathogens while also being implicated in cancer surveillance and autoimmunity. The β-chain’s expression profile can be used diagnostically and therapeutically—for example, tracking clonal expansions in leukemia/lymphoma or engineering targeted cellular therapies against tumors expressing defined antigens[1][2][4].

Other names

TCR beta variable regionTCRB V segmentTRBV (gene family abbreviation)Beta chain V domain of the T-cell antigen receptor

Drugs or therapies targeting this molecule typically act by one or more of these mechanisms: Redirecting antigen specificity via engineered receptors on patient-derived lymphocytes; Depleting pathogenic or malignant clones by recognizing unique CDR3 sequences in their β-chain variable regions; Monitoring clonal expansion as a biomarker for therapy response.